CIAM
ANIP icon

Caitong International Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

Caitong International Asset Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-231
Closed -$18.2K – 2583
2025
Q4 		$18.2K Sell
231
-189
-45% -$16.4K ﹤0.01% 1014
2025
Q3 		$38.5K Sell
420
-101
-19% -$8.24K 0.03% 410
2025
Q2 		$34K Buy
521
+510
+4,636% +$33.2K 0.02% 359
2025
Q1 		$736 Buy
+11
New +$657 ﹤0.01% 1658

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Caitong International Asset Management's ANIP Position: Q1 2026 in Review

Caitong International Asset Management sold out of ANI Pharmaceuticals (ANIP) in Q1 2026, closing a stake of 231 shares — an estimated $18.2K sold.

Caitong International Asset Management first reported a position in ANIP in Q1 2025 and held it in 4 quarters. The position peaked at $38.5K in Q3 2025. 281 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • Caitong International Asset Management reported no remaining ANI Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 231 ANI Pharmaceuticals shares in Q1 2026, an estimated $18.2K.
  • Caitong International Asset Management first reported a position in ANI Pharmaceuticals in Q1 2025 and held it in 4 quarters.
  • Caitong International Asset Management's ANI Pharmaceuticals position peaked at $38.5K in Q3 2025.
  • 281 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.